Fragile x syndrome and autism: from disease model to therapeutic targets.
about
Assessing and Stabilizing Aberrant Neuroplasticity in Autism Spectrum Disorder: The Potential Role of Transcranial Magnetic StimulationChanges in plasticity across the lifespan: cause of disease and target for interventionPerspective-taking abilities in the balance between autism tendencies and psychosis pronenessUse of transcranial magnetic stimulation in autism spectrum disordersDistinctive behavioral and cellular responses to fluoxetine in the mouse model for Fragile X syndrome.Effect of anodal transcranial direct current stimulation on autism: a randomized double-blind crossover trial.Neuroimaging endophenotypes in animal models of autism spectrum disorders: lost or found in translation?Visual sensorial impairments in neurodevelopmental disorders: evidence for a retinal phenotype in Fragile X SyndromeHyperplasticity in Autism Spectrum Disorder confers protection from Alzheimer's disease.Abnormal modulation of corticospinal excitability in adults with Asperger's syndrome.Reduced subcortical glutamate/glutamine in adults with autism spectrum disorders: a [¹H]MRS study.Epileptic Electroencephalography Profile Associates with Attention Problems in Children with Fragile X Syndrome: Review and Case Series.Metabotropic glutamate receptor-mediated long-term depression: molecular mechanisms.mGluR antagonists and GABA agonists as novel pharmacological agents for the treatment of autism spectrum disorders.Oxytocin: parallel processing in the social brain?Autism: Oxytocin, serotonin, and social reward.Excitatory/inhibitory imbalance in autism spectrum disorders: Implications for interventions and therapeutics.Early postnatal exposure to isoflurane causes cognitive deficits and disrupts development of newborn hippocampal neurons via activation of the mTOR pathway.Abnormal Mechanisms of Plasticity and Metaplasticity in Autism Spectrum Disorders and Fragile X Syndrome.mGluR5 knockout mice display increased dendritic spine densities.
P2860
Q26781536-24103B89-540D-4391-AE80-2D24F8543CDFQ27022671-3D1935AE-0DE2-458C-B1C7-7A4F33BB0D56Q27330208-1255E2A7-93BD-4BC7-9CCE-73769363B327Q28300252-AB3FDB3D-AFF1-460B-AE63-DAAAE9F21ED8Q33676486-1D1E88FB-794A-4245-8411-45D570AF07C0Q34501338-6A6BC2ED-4C94-48B6-B7C5-E9250B6A20ADQ34817846-BC79F6F0-41AE-474C-8D66-D5BD9D5AB78CQ35230774-63FCA57D-8C80-4EA0-A6F4-DB31AF31BEDBQ35360558-623EA185-9BC0-48DB-87B5-2D8523989202Q36474435-B13DE0C9-4C9D-47F1-BC21-D573114DA9AEQ37065273-13AEADDB-B66A-4ED7-B8A7-B7E92EFA1CC5Q37087429-256EBF3B-0F24-40B9-96BC-BEEFCB5BB2D8Q37635588-73A9473D-32E1-462E-BDF3-82F5FFBB56EBQ38046662-EF3EACCC-CF12-455A-8CE9-9C6B8D835DE3Q38442124-98329CF3-BBE6-4D2B-BC88-7A5588B0B9EEQ38575839-6DEAD926-A08C-4020-814C-92ABA1C99FDCQ38607739-069201BF-8194-466A-9808-2DBEE3EA1D99Q40951791-1B2D7088-580B-4F35-9FF2-92E7D55633E4Q42071146-924CE6D1-F495-4E0C-88C1-18C06AFBDBC3Q43068213-7DCB68E1-43BD-4889-83CE-A92871A251A7
P2860
Fragile x syndrome and autism: from disease model to therapeutic targets.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Fragile x syndrome and autism: from disease model to therapeutic targets.
@ast
Fragile x syndrome and autism: from disease model to therapeutic targets.
@en
type
label
Fragile x syndrome and autism: from disease model to therapeutic targets.
@ast
Fragile x syndrome and autism: from disease model to therapeutic targets.
@en
prefLabel
Fragile x syndrome and autism: from disease model to therapeutic targets.
@ast
Fragile x syndrome and autism: from disease model to therapeutic targets.
@en
P2860
P1476
Fragile x syndrome and autism: from disease model to therapeutic targets.
@en
P2093
Mark F Bear
P2860
P2888
P304
P356
10.1007/S11689-009-9015-X
P577
2009-05-12T00:00:00Z